F.L. Putnam Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Sell
104,357
-5,795
-5% -$152K 0.03% 264
2026
Q1
$3.09M Buy
110,152
+14,242
+15% +$379K 0.05% 203
2025
Q4
$2.39M Buy
95,910
+206
+0.2% +$5.2K 0.03% 237
2025
Q3
$2.44M Sell
95,704
-12,200
-11% -$301K 0.04% 235
2025
Q2
$2.62M Buy
107,904
+298
+0.3% +$6.95K 0.04% 218
2025
Q1
$2.73M Sell
107,606
-87,651
-45% -$2.29M 0.05% 205
2024
Q4
$5.18M Sell
195,257
-39,346
-17% -$1.07M 0.09% 155
2024
Q3
$6.86M Sell
234,603
-13,843
-6% -$404K 0.12% 140
2024
Q2
$6.95M Sell
248,446
-107
-0% -$2.95K 0.13% 132
2024
Q1
$6.9M Sell
248,553
-33,095
-12% -$918K 0.15% 125
2023
Q4
$8.11M Sell
281,648
-10,089
-3% -$305K 0.19% 110
2023
Q3
$9.68M Sell
291,737
-8,526
-3% -$302K 0.27% 86
2023
Q2
$11M Buy
300,263
+76,051
+34% +$2.96M 0.3% 76
2023
Q1
$9.15M Buy
224,212
+85,334
+61% +$3.69M 0.3% 83
2022
Q4
$7.12M Sell
138,878
-7,548
-5% -$362K 0.26% 89
2022
Q3
$6.41M Buy
146,426
+8,589
+6% +$417K 0.25% 93
2022
Q2
$7.23M Sell
137,837
-355
-0.3% -$18.1K 0.27% 90
2022
Q1
$7.15M Sell
138,192
-1,331
-1% -$69.1K 0.23% 90
2021
Q4
$8.24M Buy
139,523
+2,489
+2% +$123K 0.25% 81
2021
Q3
$5.89M Sell
137,034
-4,444
-3% -$197K 0.2% 101
2021
Q2
$5.54M Sell
141,478
-5,696
-4% -$222K 0.19% 102
2021
Q1
$5.33M Sell
147,174
-5,033
-3% -$179K 0.23% 87
2020
Q4
$5.6M Sell
152,207
-14,183
-9% -$520K 0.26% 80
2020
Q3
$5.79M Buy
166,390
+2,572
+2% +$90.2K 0.32% 73
2020
Q2
$5.08M Buy
163,818
+1,383
+0.9% +$47K 0.3% 75
2020
Q1
$5.03M Sell
162,435
-13,771
-8% -$469K 0.38% 64
2019
Q4
$6.55M Sell
176,206
-23,229
-12% -$827K 0.4% 71
2019
Q3
$6.8M Buy
199,435
+21,151
+12% +$769K 0.48% 63
2019
Q2
$7.33M Sell
178,284
-1,945
-1% -$77.2K 0.59% 58
2019
Q1
$7.26M Buy
180,229
+9,138
+5% +$366K 0.61% 55
2018
Q4
$7.09M Buy
171,091
+34,286
+25% +$1.42M 0.77% 44
2018
Q3
$5.72M Buy
136,805
+801
+0.6% +$30.8K 0.52% 63
2018
Q2
$4.68M Buy
136,004
+449
+0.3% +$15.3K 0.45% 66
2018
Q1
$4.56M Buy
135,555
+1,635
+1% +$56.2K 0.42% 74
2017
Q4
$4.6M Sell
133,920
-3,658
-3% -$125K 0.42% 73
2017
Q3
$4.66M Buy
+137,578
New +$4.42M 0.44% 69
2017
Q1
$1.03M Buy
31,751
+2,857
+10% +$90.1K 0.11% 131
2016
Q4
$890K Sell
28,894
-966
-3% -$29.5K 0.1% 123
2016
Q3
$960K Buy
29,860
+3,099
+12% +$104K 0.11% 117
2016
Q2
$894K Buy
26,761
+1,706
+7% +$54.4K 0.11% 112
2016
Q1
$705K Sell
25,055
-139
-0.6% -$3.97K 0.08% 110
2015
Q4
$772K Buy
25,194
+510
+2% +$16K 0.09% 116
2015
Q3
$736K Hold
24,684
0.09% 120
2015
Q2
$785K Buy
24,684
+438
+2% +$14.3K 0.09% 122
2015
Q1
$800K Buy
24,246
+190
+0.8% +$6.04K 0.09% 125
2014
Q4
$711K Sell
24,056
-1,706
-7% -$48.9K 0.08% 133
2014
Q3
$723K Sell
25,762
-627
-2% -$17.6K 0.09% 140
2014
Q2
$743K Sell
26,389
-753
-3% -$21.5K 0.09% 143
2014
Q1
$827K Sell
27,142
-296
-1% -$8.83K 0.1% 143
2013
Q4
$797K Sell
27,438
-45,872
-63% -$1.34M 0.1% 141
2013
Q3
$2M Buy
73,310
+5,543
+8% +$151K 0.27% 99
2013
Q2
$1.8M Buy
+67,767
New +$1.87M 0.26% 101

Other funds holding PFE

F.L. Putnam Investment Management's PFE Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its Pfizer (PFE) stake by 5.3% in Q2 2026, selling an estimated $152K and leaving 104,357 shares worth $2.51M. The position accounts for 0.03% of the portfolio, ranked #264.

F.L. Putnam Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11M in Q2 2023. 1,944 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • F.L. Putnam Investment Management held 104,357 shares of Pfizer worth $2.51M as of Q2 2026.
  • F.L. Putnam Investment Management sold 5,795 Pfizer shares in Q2 2026, an estimated $152K.
  • Pfizer made up 0.03% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #264 holding.
  • F.L. Putnam Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • F.L. Putnam Investment Management's Pfizer position peaked at $11M in Q2 2023.
  • 1,944 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.